[CERT] Satellos Bioscience Inc. Certification Filing

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

CERT

Rhea-AI Filing Summary

Analyzing...

02/06/2026 - 08:14 AM

CERT - Satellos Bioscience Inc.

CERT Filing - Satellos Bioscience Inc.

This filing is available as a PDF document.

Filing Type: CERT

Company: Satellos Bioscience Inc. (MSCLF)

Acceptance Date: 2026-02-06T08:14:22.000Z

View PDF Document

Source: View Original Filing on SEC EDGAR

Satellos Bioscience Inc

OTC:MSCLF

MSCLF Rankings

N/A Ranked by Market Cap

N/A Ranked by Dividends

MSCLF Latest News

Feb 5, 2026

Satellos Announces Launch of Public Offering in Canada and the United States and Filing of Application to List on Nasdaq

Jan 29, 2026

Satellos Appoints Antoinette Paone as Chief Development Officer and Head of Regulatory Affairs

Jan 28, 2026

Satellos Announces Share Consolidation in Connection with Proposed Nasdaq Listing

Dec 9, 2025

Satellos Receives Clearance by U.S. FDA and Global Regulators to Initiate Pediatric Phase 2 Study of SAT-3247 for Duchenne Muscular Dystrophy

Nov 25, 2025

Satellos to Participate in December Investor Conferences

MSCLF Latest SEC Filings

Feb 6, 2026

[6-K] Satellos Bioscience Inc. Current Report (Foreign Issuer)

Feb 5, 2026

[F-10] Satellos Bioscience Inc. SEC Filing

MSCLF Stock Data

Market Cap 89.92M

Float 169.88M

Insiders Ownership 8.74%

Institutions Ownership 8.67%

Industry Biotechnology

Sector Healthcare

Website Link

Country Canada

City Toronto